Ownership

Sanjay Shukla - President and CEO, Director at aTYR PHARMA INC

Insider Transactions and Holdings

Entity Type: Individual
Role: President and CEO, Director
Stock Symbol: ATYR on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Sanjay Shukla - trading volume in the past year for aTYR PHARMA INC

	Shares	%	Avg Price	Total $
Buys	+20K	100%	$1.81	+$36.1K
Sells
Net	+20K	100%		+$36.1K

Showing 1 to 3 of 3 entries

Holdings reported by Sanjay Shukla for aTYR PHARMA INC

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	147K	$555K	$3.78	Feb 3, 2025	Direct
Restricted Stock Unit	10.4K	$39.2K	$3.78	Feb 3, 2025	Direct	Common Stock
Restricted Stock Unit	20.8K	$35.1K	$1.69	Feb 5, 2024	Direct	Common Stock
Employee Stock Option (right to buy)	1M			Jan 8, 2025	Direct	Common Stock

Transactions reported by Sanjay Shukla for aTYR PHARMA INC

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.